Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Epigenomics|November 8, 2012
Chromatin regulators with tumor suppressor properties and their alterations in human cancersXing-Sheng Shu, Lili Li, Qian Tao
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 9, 2023
Targeting cancer metabolic vulnerabilities for advanced therapeutic efficacyTobias Achu Muluh, Xing-Sheng Shu, Ying Ying
Neuropharmacology|February 14, 2021
Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathyKostadin Dimov Rolev, Xing-Sheng Shu, Ying Ying
Chinese Journal of Cancer|March 29, 2011
Epigenetic disruption of cell signaling in nasopharyngeal carcinomaLi-Li Li, Xing-Sheng Shu, Zhao-Hui Wang, et al.
Oncotarget|April 14, 2017
OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinomaYixiang Zhang, Yeqing Yuan, Pei Liang, et al.
Aging|June 24, 2020
Loss of β-catenin via activated GSK3β causes diabetic retinal neurodegeneration by instigating a vicious cycle of oxidative stress-driven mitochondrial impairmentXing-Sheng Shu, Huazhang Zhu, Xiaoyan Huang, et al.
Cell Death & Disease|January 7, 2023
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancerYongheng Chen, Ying Ying, Maolin Wang, et al.
The Journal of Pathology|September 24, 2017
The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancerXing-Sheng Shu, Yingying Zhao, Yanmei Sun, et al.
Antioxidants & Redox Signaling|July 3, 2024
Targeting Ferroptosis as an Advance Strategy in Cancer TherapyTobias Achu Muluh, Qianqian Fu, Xiaojiao Ai, et al.
Frontiers in Oncology|December 3, 2021
A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon CancerMaolin Wang, Xing-Sheng Shu, Meiqi Li, et al.
Pageof 3